Gold Nano-Factories Can Enter Cancer Tumors to Deliver Meds

Molecular Machines, also called Nano-factories, have been created that can insert themselves in cancer tumors and deliver targeted meds to the undesired cells, limiting the amount of damage to surrounding healthy cells.

The nano-factories come from gold nanoparticles

“Nano-factories” produce anti-cancer drugs from inside tumors

…..scientists at the Technion have developed a way to sneak synthetic cells right into tumor tissue, where they then begin producing cancer-fighting proteins from the inside. The technique was tested in both cell cultures and in mice, and found to be an effective treatment in both cases.

Cancer cells thrive thanks to some robust defense mechanisms, so finding ways to get past them is a key area of research. In the past, scientists have sent gold nanoparticles inside tumors by hitchhiking on white blood cells, before heating the gold with near-infrared light to kill the cancer from within. Others examined the possibility of administering a “prodrug” that remained inactive until it detected cancer markers, and then began producing drugs from inside the tumor.

The new work follows a similar function as the latter. The Technion scientists loaded molecular machines inside lipid-based particles that resemble biological cell membranes, creating what they call “nano-factories.” Once they’re activated by sensing the presence of abnormal cells, these particles kick into gear, producing specific therapeutic proteins and pulling the energy and building blocks they need from the tumor tissue around them.

“By coding the integrated DNA template, the particles we developed can produce a variety of protein medicines,” says Avi Schroeder, one of the lead researchers on the study. “They are modular, meaning they allow for activation of protein production in accordance with the environmental conditions. Therefore, the artificial cells we’ve developed at the Technion may take an important part in the personalized medicine trend – adjustment of treatment to the genetic and medical profile of a specific patient.”

Read More at News Atlas
Facebook Comments
About Paul Gordon 2894 Articles
Paul Gordon is the publisher and editor of iState.TV. He has published and edited newspapers, poetry magazines and online weekly magazines. He is the director of Social Cognito, an SEO/Web Marketing Company. You can reach Paul at pg@istate.tv